Actively Recruiting
Early Detection of OAB and Elimination of Negative Impact on Quality of Life
Led by Institute of Health Information and Statistics of the Czech Republic · Updated on 2026-01-27
1000
Participants Needed
20
Research Sites
52 weeks
Total Duration
On this page
Sponsors
I
Institute of Health Information and Statistics of the Czech Republic
Lead Sponsor
G
General University Hospital, Prague
Collaborating Sponsor
AI-Summary
What this Trial Is About
Overactive bladder (OAB) is one of the most common health problems in the adult population. The goal of this project is to improve the awareness of the problem and to correctly refer the targeted persons to a specialist or a doctor. This will be provided by an online screening tool, designed as web platform and mobile application, where the data will be stored in respect to GDPR. People with a positive result from the online screening tool will be offered an examination by a specialist (gynaecologist, urogynaecologist, urologist) involved in the project. The specialist will have access to the results from the online screening tool - he/she will log into the web platform with a view of the participants profile. He/she will perform the diagnosis, confirm or refute the diagnosis and complement it with any further diagnostic tests and set the standard treatment.
CONDITIONS
Official Title
Early Detection of OAB and Elimination of Negative Impact on Quality of Life
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed Consent to Participate in the Project and Consent to the Processing of Personal Data (online and paper format)
- Men and women over 18 years of age with increased urinary frequency (more than 7 times in 24 hours)
- Optional inclusion: nycturia and/or urge incontinence
You will not qualify if you...
- Unsigned Consent to Participate in the Project and Consent to the Processing of Personal Data
- Current treatment of OAB, acute problems, or suspicion of another disease causing OAB symptoms (haematuria, suspected bladder cancer, etc.)
- Inflammation of the lower urinary tract
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 20 locations
1
Brno University Hospital
Brno, Czechia
Not Yet Recruiting
2
GYN-LINE, s.r.o.
Brno, Czechia
Not Yet Recruiting
3
České Budějovice Hospital
České Budějovice, Czechia
Not Yet Recruiting
4
Hospital Hořovice
Hořovice, Czechia
Not Yet Recruiting
5
University Hospital Hradec Králové
Hradec Králové, Czechia
Not Yet Recruiting
6
Hospital Jablonec nad Nisou
Jablonec nad Nisou, Czechia
Not Yet Recruiting
7
AGYNO s.r.o.
Karlovy Vary, Czechia
Not Yet Recruiting
8
Oblastní nemocnice Kolín a.s.
Kolín, Czechia
Not Yet Recruiting
9
Olomouc University Hospital
Olomouc, Czechia
Not Yet Recruiting
10
GYNOVA s.r.o.
Ostrava, Czechia
Not Yet Recruiting
11
Hospital AGEL Ostrava - Vítkovice a.s.
Ostrava, Czechia
Not Yet Recruiting
12
University Hospital Ostrava
Ostrava, Czechia
Not Yet Recruiting
13
Gyncare Michael Švec s.r.o.
Pilsen, Czechia
Not Yet Recruiting
14
Mulačova nemocnice
Pilsen, Czechia
Not Yet Recruiting
15
General University Hospital
Prague, Czechia
Actively Recruiting
16
GynUp! s.r.o.
Prague, Czechia
Not Yet Recruiting
17
University Hospital Bulovka
Prague, Czechia
Not Yet Recruiting
18
University Thomayer Hospital
Prague, Czechia
Not Yet Recruiting
19
Uroklinikum s.r.o.
Prague, Czechia
Not Yet Recruiting
20
Sokolov Hospital
Sokolov, Czechia
Not Yet Recruiting
Research Team
K
Kateřina Ondrášková, Msc
CONTACT
L
Lucie Mandelová, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here